The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia
Open Access
- 16 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (16) , 10156
Abstract
The use of international nonproprietary names (INNs) has been mandatory for prescriptions of state-reimbursed drugs in Latvia since 1 April 2020. In a retrospective analysis, we aimed to examine the impact of the new regulation on changes in the prescribing and dispensing practice of antihypertensive agents with an example of bisoprolol or/and perindopril and their combinations. All state-reimbursed bisoprolol and/or perindopril prescriptions for arterial hypertension were evaluated in two time periods: 1 April 2018 to 31 March 2019 and 1 April 2020 to 31 March 2021. The proportion of INN prescriptions increased from 2.1% to 92.3% (p < 0.001, φ = 0.903). The rate of fixed-dose combinations (FDCs) increased from 60.8% to 66.5% (p < 0.001, φ = 0.059). The rate of medication errors was 0.6%. The most common (80.6%) error was that the dispensed medicine dose was larger or smaller than indicated on the prescription. In addition, prescribing an FDC medicine increased the chance of making an error by 2.5 times on average. Regulatory changes dramatically affected the medicine-prescribing habits of INNs. The increase in FDC prescription rates may align with the recommendations of the 2018 ESC/ESH guidelines. The proportion of total errors is estimated as low, but control mechanisms are needed to prevent them.Keywords
This publication has 17 references indexed in Scilit:
- The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?F1000Research, 2020
- Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinibJournal of Pharmaceutical Policy and Practice, 2020
- Knowledge about Disease, Medication Therapy, and Related Medication Adherence Levels among Patients with HypertensionMedicina, 2019
- Use of generic medicines in Latvia: awareness, opinions and experiences of the populationJournal of Pharmaceutical Policy and Practice, 2019
- Fixed‐dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implicationsThe Journal of Clinical Hypertension, 2018
- State of Health in the EU. Greece. Country Health Profile 2017European Journal of Public Health, 2018
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionEuropean Heart Journal, 2018
- Preventing medication errors in community pharmacy: frequency and seriousness of medication errorsQuality and Safety in Health Care, 2007
- National Observational Study of Prescription Dispensing Accuracy and Safety in 50 PharmaciesJournal of the American Pharmaceutical Association, 2003
- International Nonproprietary Names (INN) for pharmaceutical substances.1995